On December 7, 2025, the 2025 Changchun International Pharmaceutical and Health Industry Expo and the Changbai Mountain Ginseng Industry High-Quality Development Conference grandly opened. Guided by the core principles of “distinctiveness, internationalization, leadership, professionalism, and public participation,” the three-day expo comprehensively gathered global industry resources and cutting-edge wisdom, aiming to create a high-end platform integrating achievement display, in-depth exchange, and strategic cooperation. It not only vividly showcased the latest developments and future trends in the pharmaceutical and health industry but also injected new and strong momentum into the innovation and high-quality development of the biopharmaceutical industry in the Changchun modern metropolitan area and even the wider region.
In the highly anticipated Hong Kong, Macao, Taiwan, and Overseas Chinese exhibition area, CMA Testing made a brilliant appearance with its professional solutions. At the “Changchun-Hong Kong-Macao-Overseas Chinese Medicine Overseas Matchmaking Conference” held during the expo, Ms. Sarah Cui, General Manager of CMA Testing East China, delivered a keynote speech entitled “Hong Kong as a Bridge for Chinese Enterprises Going Global.” Drawing on extensive practical experience, she elaborated on how CMA Testing, with its comprehensive service capabilities in international registration and compliance testing of traditional Chinese medicine, compliance verification of food-medicine homology products, efficacy and safety testing of functional foods, and intellectual property protection and patent application strategies in related fields, helps companies meet the challenges of going global. She particularly pointed out that Hong Kong, as an international hub, is a key node connecting the mainland and global markets, bridging different regulatory systems and standards. CMA Testing’s professional services can effectively assist companies in overcoming technical barriers and efficiently completing product access and brand development.
Go Global Case
As a member company of the CMA+ technology commercialization platform “InnoLIFE”, Ginpact also participated in this exhibition. The brand commissioned CMA Testing to conduct a compliance audit of its high-quality ginseng products, covering the products themselves and packaging labels, and successfully obtained authorization to use CMA Testing “A+” label.
This matchmaking event attracted representatives from over thirty institutions in Macau and Hong Kong, along with fifteen key local enterprises in Changchun. They engaged in lively and pragmatic discussions on the cross-border development and international cooperation of the traditional Chinese medicine (TCM) industry. Representatives actively shared experiences, aligned their needs, and jointly explored new opportunities, models, and pathways for TCM to go global. CMA Testing’s deep involvement and professional sharing not only demonstrated its service capabilities in supporting the international development of China’s pharmaceutical and healthcare industry but also, through the high-level platform of this expo, further deepened regional collaboration and international cooperation, contributing professional expertise to building a new open and win-win ecosystem for the pharmaceutical and healthcare industry.
